References
- International Diabetes Federation . Diabetes atlas (2013). www.diabetesatlas.org/.
- AACE Diabetes Outpatient Resource Center . http://outpatient.aace.com/.
- Diabetes basics: Type 1. www.diabetes.org/diabetes-basics/type-1/?loc=util-header_type1.
- Walsh J Roberts R . Other reasons for erratic readings. In : Pumping Insulin: Everything for Success on a Pump and CGM (6th Edition). Torrey Pines Pr, CA, USA (2016).
- Gonder-Frederick LA Shepard JA Grabman JH Ritterband LM . Psychology, technology and diabetes management. Am. Psychol.71 (7), 577–589 (2016).
- Wisting L Bang L Skrivarhaug T Dahl-Jorgensen K Ro O . Psychological barriers to optimal insulin therapy: more concerns in adolescent females than males. BMJ Open Diabetes Res. Care4 (1), e000203 (2016).
- Wisting L Bang L Natvig H et al. Metabolic control and illness perceptions in adolescents with Type 1 diabetes. J. Diabetes Res. 2016, 3486094 (2016).
- The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med.329 (14), 977–986 (1993).
- Handelsman Y Bloomgarden ZT Grunberger G et al. American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015. Endocr. Pract.21 (Suppl. 1), 1–87 (2015).
- American Diabetes Association . Standards of medical care in diabetes. Diabetes Care: The journal of Clinical and Applied Research and Education40 (1), S4–S5 (2017).
- International Diabetes Federation . Global IDF/ISPAD guideline for diabetes in childhood and adolescence (2011). www.ispad.org/?page=IDFISPAD2011.
- Schwandt A Best F Biester T et al. Both the frequency of HbA1c testing and the frequency of self-monitoring of blood glucose predict metabolic control: a multicenter analysis of 15,199 adult Type 1 diabetes patients from Germany and Austria. Diabetes Metab. Res. Rev.33 (7), doi:10.1002/dmrr.2908 (2017) ( Epub ahead of print).
- Schutt M Kern W Krause U et al. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Exp. Clin. Endocrinol. Diabetes114 (7), 384–388 (2006).
- Hortensius J Kars MC Wierenga WS et al. Perspectives of patients with Type 1 or insulin-treated Type 2 diabetes on self-monitoring of blood glucose: a qualitative study. BMC Public Health12, 167 (2012).
- Karges B Schwandt A Heidtmann B et al. Association of insulin pump therapy versus insulin injection therapy with severe hypoglycemia, ketoacidosis and glycemic control among children, adolescents and young adults with Type 1 diabetes. JAMA318 (14), 1358–1366 (2017).
- Pfützner A Bailey T Campos C et al. Accuracy and preference assessment of prefilled insulin pen versus vial and syringe with diabetes patients, caregivers and healthcare professionals. Curr. Med. Res. Opin.29 (5), 475–481 (2013).
- Aronson R Reznik Y Conget I et al. Sustained efficacy of insulin pump therapy compared with multiple daily injections in Type 2 diabetes: 12-month data from the OpT2mise randomized trial. Diabetes Obes. Metab.18 (5), 500–507 (2016).
- Castle JR Jacobs PG . Nonadjunctive use of continuous glucose monitoring for diabetes treatment decisions. J. Diabetes Sci. Technol.10 (5), 1169–1173 (2016).
- Walsh J Roberts R Bailey T . Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels. J. Diabetes Sci. Technol.4 (5), 1174–1181 (2010).
- Lau YN Korula S Chan AK Heels K Krass I Ambler G . Analysis of insulin pump settings in children and adolescents with Type 1 diabetes mellitus. Pediatr. Diabetes17 (5), 319–326 (2016).
- Albisser AM Leibel BS Ewart TG Davidovac Z Botz CK Zingg W . An artificial endocrine pancreas. Diabetes23 (5), 389–396 (1974).
- Kraegen EW Campbell LV Chia YO Meler H Lazarus L . Control of blood glucose in diabetics using an artificial pancreas. Aust. NZ J. Med.7 (3), 280–286 (1977).
- Turksoy K Cinar A . Adaptive control of artificial pancreas systems - a review. J. Healthc. Eng.5 (1), 1–22 (2014).
- Weiss R Garg SK Bode BW et al. Hypoglycemia reduction and changes in hemoglobin A1c in the ASPIRE in-home study. Diabetes Technol. Ther.17 (8), 542–547 (2015).
- Buckingham BA Raghinaru D Cameron F et al. Predictive low-glucose insulin suspension reduces duration of nocturnal hypoglycemia in children without increasing ketosis. Diabetes Care38 (7), 1197–1204 (2015).
- Haidar A Messier V Legault L Ladouceur M Rabasa-Lhoret R . Outpatient 60-h day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas or sensor-augmented pump therapy in adults with Type 1 diabetes: an open-label, randomized, crossover, controlled trial. Diabetes Obes. Metab.19 (5), 713–720 (2017).
- Taleb N Haidar A Messier V Gingras V Legault L Rabasa-Lhoret R . Glucagon in artificial pancreas systems: potential benefits and safety profile of future chronic use. Diabetes Obes. Metab.19 (1), 13–23 (2017).
- Doyle FJ 3rd Huyett LM Lee JB Zisser HC Dassau E . Closed-loop artificial pancreas systems: engineering the algorithms. Diabetes Care37 (5), 1191–1197 (2014).
- Ang KH Tamborlane WV Weinzimer SA . Combining glucose monitoring and insulin delivery into a single device: current progress and ongoing challenges of the artificial pancreas. Expert Opin. Drug Deliv.12 (10), 1579–1582 (2015).
- Castle JR Devries JH Kovatchev B . Future of automated insulin delivery systems. Diabetes Technol. Ther.19 (S3), S67–S72 (2017).
- U.S. Food & Drug Administration . Summary of safety and effectiveness data (SSED) of the medtronic MiniMed 670G System (2016). www.accessdata.fda.gov/cdrh_docs/pdf16/P160017b.pdf.
- Innovations in Progress. www.tandemdiabetes.com/about-us/pipeline.
- Biomedical B . Abbott and bigfoot biomedical announce collaboration to develop breakthrough diabetes technologies (2017). www.prnewswire.com/news-releases/abbott-and-bigfoot-biomedical-announce-collaboration-to-develop-breakthrough-diabetes-technologies-300487596.html.
- Trevitt S Simpson S Wood A . Artificial pancreas device systems for the closed-loop control of Type 1 diabetes: what systems are in development?J. Diabetes Sci. Technol.10 (3), 714–723 (2016).
- Insulet Corporation . Insulet presents positive Omnipod® Horizon™ hybrid closed-loop study results in children (2017). www.businesswire.com/news/home/20170612005299/en/Insulet-Presents-Positive-Omnipod%C2%AE-Horizon%E2%84%A2-Hybrid-Closed-Loop.
- Blauw H Van Bon AC Koops R Devries JH . Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at home. Diabetes Obes. Metab.18 (7), 671–677 (2016).
- Updates: CE certification is halfway! https://inredadiabetic.nl/en/news/ce-certification-halfway/.
- Cellnovo . Cellnovo acquires commercial license for artificial pancreas technology from TypeZero technologies (2017). www.businesswire.com/news/home/20170417005104/en/Cellnovo-Acquires-Commercial-License-Artificial-Pancreas-Technology.
- Ly TT Roy A Grosman B et al. Day and night closed-loop control using the integrated Medtronic hybrid closed-loop system in Type 1 diabetes at diabetes camp. Diabetes Care38 (7), 1205–1211 (2015).
- Heinemann L Freckmann G . CGM versus FGM; or, continuous glucose monitoring is not flash glucose monitoring. J. Diabetes Sci. Technol.9 (5), 947–950 (2015).
- Medtronic . MiniMed 670G system user guide (2016). www.medtronicdiabetes.com/sites/default/files/library/download-library/user-guides/MP6026157-011_b.pdf.
- Smartguard low management suspend quick reference. www.medtronicdiabetes.com/customer-support/minimed-670g-system-support/smartguard-quick-reference.
- Bergenstal RM Garg S Weinzimer SA et al. Safety of a hybrid closed-loop insulin delivery system in patients with Type 1 diabetes. JAMA316 (13), 1407–1408 (2016).
- U.S. Food & Drug Administration . OIR lead-post approval study (2017). www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma_pas.cfm?t_id=600378&c_id=4560.
- FDA approves Medtronic's MiniMed 630G system, ships in September. https://diatribe.org/fda-approves-medtronic-minimed-630g-system.
- Cameron FM Ly TT Buckingham BA et al. Closed-loop control without meal announcement in Type 1 diabetes. Diabetes Technol. Ther.19 (9), 527–532 (2017).
- Bailey TS . Clinical implications of accuracy measurements of continuous glucose sensors. Diabetes Technol. Ther.19 (S2), S51–S54 (2017).